EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹15 Cr | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹11 Cr |
How is Total Non-Current Liabilities of EVEREST ORGANICS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 Cr | -29.69 | |
| Mar2024 | ₹21 Cr | 15.12 | |
| Mar2023 | ₹18 Cr | -3.16 | |
| Mar2022 | ₹19 Cr | 62.92 | |
| Mar2021 | ₹11 Cr | - | |
Compare Total Non-Current Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹197.3 Cr | -27.6% | -45.7% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -27.6% |
-45.7% |
-7.3% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses